We are live on ! Find out more
TPCW

TD Private Client Wealth Portfolio holdings

AUM $4.82B
1-Year Est. Return 15.21%
This Fund
S&P 500
This Quarter Est. Return
-16.13%
1 Year Est. Return
+15.21%
3 Year Est. Return
+48.23%
5 Year Est. Return
+55.79%
10 Year Est. Return
AUM
$1.4B
AUM Growth
-$273M
Cap. Flow
+$44.2M
Cap. Flow %
3.16%
Top 10 Hldgs %
30.51%
Holding
1,145
New
78
Increased
445
Reduced
411
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 9.02%
2 Healthcare 8.62%
3 Financials 7.1%
4 Communication Services 5.68%
5 Consumer Staples 4.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMCX icon
951
AMC Global Media
AMCX
$430M
$632 ﹤0.01%
26
-14
-35% -$474
IRDM icon
952
Iridium Communications
IRDM
$4.85B
$625 ﹤0.01%
28
PCTY icon
953
Paylocity
PCTY
$6.71B
$618 ﹤0.01%
7
ITCI
954
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$599 ﹤0.01%
39
BRX icon
955
Brixmor Property Group
BRX
$9.95B
$589 ﹤0.01%
+62
New +$1.11K
VIRT icon
956
Virtu Financial
VIRT
$5.2B
$583 ﹤0.01%
28
-43
-61% -$794
TDC icon
957
Teradata
TDC
$2.68B
$574 ﹤0.01%
28
-131
-82% -$3.02K
AWR icon
958
American States Water
AWR
$3.39B
$572 ﹤0.01%
7
CLH icon
959
Clean Harbors
CLH
$16.1B
$565 ﹤0.01%
11
-27
-71% -$1.97K
BLUE
960
DELISTED
bluebird bio
BLUE
$552 ﹤0.01%
+1
New +$975
SKYW icon
961
Skywest
SKYW
$4.11B
$550 ﹤0.01%
21
CNDT icon
962
Conduent
CNDT
$230M
$549 ﹤0.01%
224
+172
+331% +$682
KRO icon
963
KRONOS Worldwide
KRO
$761M
$506 ﹤0.01%
+60
New +$630
RVNC
964
DELISTED
Revance Therapeutics, Inc.
RVNC
$503 ﹤0.01%
34
FORM icon
965
FormFactor
FORM
$8.11B
$502 ﹤0.01%
25
SIGI icon
966
Selective Insurance
SIGI
$5.74B
$497 ﹤0.01%
10
INVH icon
967
Invitation Homes
INVH
$17.7B
$492 ﹤0.01%
23
BGS icon
968
B&G Foods
BGS
$285M
$488 ﹤0.01%
27
+2
+8% +$31
MAC icon
969
Macerich
MAC
$7.32B
$484 ﹤0.01%
86
-58
-40% -$1.15K
RLJ icon
970
RLJ Lodging Trust
RLJ
$1.87B
$479 ﹤0.01%
+62
New +$833
ORA icon
971
Ormat Technologies
ORA
$6.11B
$474 ﹤0.01%
7
WPC icon
972
W.P. Carey
WPC
$17.1B
$465 ﹤0.01%
8
-39
-83% -$2.96K
NAVI icon
973
Navient
NAVI
$774M
$462 ﹤0.01%
61
-98
-62% -$1.17K
SAGE
974
DELISTED
Sage Therapeutics
SAGE
$460 ﹤0.01%
16
+4
+33% +$232
IIPR icon
975
Innovative Industrial Properties
IIPR
$1.78B
$456 ﹤0.01%
6

Similar funds

TD Private Client Wealth's Q1 2020 Portfolio in Review

As of Q1 2020, TD Private Client Wealth held 1,145 positions worth $1.4B, down 16% from $1.67B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

TD Private Client Wealth deployed $44.2M of net new capital in Q1 2020, opening 78 new positions and adding to 445 existing holdings. Its largest new stake was GSK: 113,929 shares worth $5.4M.

By sector, the portfolio is most concentrated in Technology at 9% of assets, up from 8.2% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard Short-Term Corporate Bond ETF, an estimated $29M trimmed.

  • TD Private Client Wealth's largest Q1 2020 buy was GSK: 113,929 shares worth $5.4M.
  • TD Private Client Wealth added most to iShares 1-3 Year Treasury Bond ETF in Q1 2020, an estimated $54.9M increase.
  • TD Private Client Wealth's biggest Q1 2020 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $29M.
  • TD Private Client Wealth fully exited State Street SPDR Bloomberg International Treasury Bond ETF in Q1 2020, selling an estimated $815K.
  • TD Private Client Wealth's ten largest holdings make up 31% of its $1.4B portfolio in Q1 2020.
  • TD Private Client Wealth opened 78 new positions and closed 74 in Q1 2020.
  • TD Private Client Wealth's portfolio value fell 16% quarter-over-quarter to $1.4B.

Based on TD Private Client Wealth's 13F filing for Q1 2020, filed 16 Aug 2024.